Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  VYNE Therapeutics Inc.    VYNE

VYNE THERAPEUTICS INC.

(VYNE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about VYNE THERAPEUTICS INC.
01/26VYNE THERAPEUTICS : Announces $50 Million Registered Direct Offering of Common S..
AQ
01/22VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ and ZILXI with Major..
AQ
01/21VYNE THERAPEUTICS : Signs Deal With Pharmacy Benefit Manager for FDA-Approved Sk..
MT
01/21VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ® (minocycline) and Z..
AQ
01/05VYNE THERAPEUTICS : to Present at the LifeSci Partners 10th Annual Healthcare Co..
AQ
2020VYNE THERAPEUTICS : Completes End-of-Phase 2 Meeting With FDA for FCD105 to Trea..
MT
2020VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for ..
GL
2020VYNE THERAPEUTICS : to Join Nasdaq Biotechnology Index
MT
2020VYNE THERAPEUTICS : Added to Nasdaq Biotechnology Index
AQ
2020VYNE THERAPEUTICS : Wins US Patent for Acne Treatment Amzeeq
MT
2020VYNE THERAPEUTICS : Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (mino..
AQ
2020VYNE Therapeutics Announces Publication of Long-term Safety & Efficacy Data f..
GL
2020VYNE THERAPEUTICS : to Present at the 32nd Annual Piper Sandler Healthcare Confe..
AQ
2020VYNE Therapeutics to Present at the 32nd Annual Piper Sandler Healthcare Conf..
GL
2020Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q3 EPS $-0.13, vs. Street Est o..
MT
More most relevant news
All news about VYNE THERAPEUTICS INC.
01/26Wall Street Wavers Pre-Bell Amid Earnings Deluge
MT
01/26VYNE THERAPEUTICS : Announces $50 Million Registered Direct Offering of Common S..
AQ
01/26VYNE THERAPEUTICS INC. : Results of Operations and Financial Condition (form 8-K..
AQ
01/22VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ and ZILXI with Major..
AQ
01/21VYNE THERAPEUTICS : Signs Deal With Pharmacy Benefit Manager for FDA-Approved Sk..
MT
01/21VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ® (minocycline) and Z..
AQ
01/07VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
01/05VYNE THERAPEUTICS : to Present at the LifeSci Partners 10th Annual Healthcare Co..
AQ
2020VYNE THERAPEUTICS : Completes End-of-Phase 2 Meeting With FDA for FCD105 to Trea..
MT
2020VYNE Therapeutics Reports Successful End-of-Phase 2 Meeting with the FDA for ..
GL
More news
News in other languages on VYNE THERAPEUTICS INC.

- No features available -

More news
Press releases
01/26VYNE THERAPEUTICS : Announces $50 Million Registered Direct Offering of Common S..
AQ
01/26VYNE THERAPEUTICS INC. : Results of Operations and Financial Condition (form 8-K..
AQ
01/22VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ and ZILXI with Major..
AQ
01/21VYNE THERAPEUTICS : Announces Contract Execution for AMZEEQ® (minocycline) and Z..
AQ
01/07VYNE THERAPEUTICS INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
More press releases